Marksans Pharma Limited (BOM:524404)
India
· Delayed Price · Currency is INR 250.40
0.00 (0.00%)
At close: Jun 18, 2025
Marksans Pharma Employees
Marksans Pharma had 1,141 employees as of March 31, 2024. The number of employees increased by 289 or 33.92% compared to the previous year.
Employees
1,141
Change (1Y)
289
Growth (1Y)
33.92%
Revenue / Employee
22.99M INR
Profits / Employee
3.34M INR
Market Cap
114.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | 1,150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 347,362 |
| HDFC Bank | 214,521 |
| Tata Consultancy Services | 607,979 |
| Bharti Airtel | 28,673 |
| ICICI Bank | 187,765 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Life Insurance Corporation of India | 98,661 |
Marksans Pharma News
- 9 days ago - Marksans Pharma’s UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution - Business Upturn
- 17 days ago - Marksans Pharma shares jump 3% after large block deal worth Rs 257 crore - Business Upturn
- 17 days ago - Marksans Pharma Block Deal: Over 1 crore shares worth Rs 257 crore change hands at Rs 249.95 per share - Business Upturn
- 4 weeks ago - Marksans Pharma’s subsidiary Relonchem gets UK MHRA approval for Metformin Hydrochloride Oral Solution - Business Upturn
- 5 weeks ago - Marksans Pharma’s UK arm gets marketing approval for Sennosides 7.5 mg tablets - Business Upturn
- 6 weeks ago - Marksans Pharma’s UK subsidiary Relonchem gets UKMHRA nod for Gabapentin oral solution - Business Upturn
- 2 months ago - Marksans Pharma’s subsidiary receives one USFDA observation after cGMP inspection at New York facility - Business Upturn
- 4 months ago - Marksans Pharma’s subsidiary Relonchem gets UK approval for Ibuprofen and Paracetamol tablets - Business Upturn